|
XRCC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63102864547682E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.93185484170999E-12 |
| Normal-vs-Stage2 |
1.555360E-03 |
| Normal-vs-Stage3 |
6.541300E-03 |
| Normal-vs-Stage4 |
4.462000E-03 |
| Stage1-vs-Stage2 |
2.902000E-01 |
| Stage1-vs-Stage3 |
7.730800E-01 |
| Stage1-vs-Stage4 |
4.188400E-01 |
| Stage2-vs-Stage3 |
5.618800E-01 |
| Stage2-vs-Stage4 |
7.957600E-01 |
| Stage3-vs-Stage4 |
7.993600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64535052249448E-12 |
| Normal-vs-AfricanAmerican |
7.18829999968307E-08 |
| Normal-vs-Asian |
5.994000E-02 |
| Caucasian-vs-AfricanAmerican |
9.589800E-01 |
| Caucasian-vs-Asian |
3.532800E-01 |
| AfricanAmerican-vs-Asian |
4.255000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65178981603731E-12 |
| Normal-vs-Female |
2.90379997824886E-09 |
| Male-vs-Female |
6.685200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.14789999999754E-05 |
| Normal-vs-Extreme_Weight |
4.62174742921206E-12 |
| Normal-vs-Obese |
2.72729949735151E-10 |
| Normal-vs-Extreme_Obese |
2.867700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.014570E-01 |
| Normal_Weight-vs-Obese |
1.981220E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.390400E-01 |
| Extreme_Weight-vs-Obese |
7.140600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.658000E-01 |
| Obese-vs-Extreme_Obese |
6.883000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.998800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.91988655476416E-14 |
| Normal-vs-Age(61-80Yrs) |
3.27600169214293E-11 |
| Normal-vs-Age(81-100Yrs) |
1.356390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.431400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.183400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.427400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.834120E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.033800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.919200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
5.57649999999299E-05 |
| Normal-VS-KIRP CIMP |
3.736200E-02 |
| Normal-VS-Unclassified PRCC |
1.83481000000096E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.88540000000726E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.220800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.632400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.007350E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.379200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.479370E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73482999999974E-05 |
| Normal-vs-N1 |
4.442700E-03 |
| Normal-vs-N2 |
1.822600E-01 |
| N0-vs-N1 |
4.796200E-01 |
| N0-vs-N2 |
9.933800E-01 |
| N1-vs-N2 |
7.535800E-01 |
|
|
